The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of static and dynamic risk assessment in HMA-treated MDS patients undergoing stem cell transplantation.
 
Luis Aguirre
No Relationships to Disclose
 
Haesook Kim
Consulting or Advisory Role - Neovii
 
Hany Elmariah
Consulting or Advisory Role - Shoreline Biosciences
Research Funding - Bristol-Myers Squibb/Pfizer
 
Stacey Frumm
No Relationships to Disclose
 
Amar Kelkar
Stock and Other Ownership Interests - Amgen; Iovance Biotherapeutics
Research Funding - CareDX
 
Vincent Ho
Consulting or Advisory Role - Alexion Pharmaceuticals; AlloVir
Research Funding - CareDX; Jazz Pharmaceuticals; Omeros
 
Mahasweta Gooptu
Consulting or Advisory Role - Syndax
Travel, Accommodations, Expenses - Syndax
 
Joseph Antin
Consulting or Advisory Role - CSL Behring; Janssen
 
Robert Soiffer
Leadership - Be the Match/NMDP; Kiadis Pharma
Consulting or Advisory Role - Alexion Pharmaceuticals; Bluesphere Bio; Cugene; Gilead Sciences; Jasper Therapeutics; Jazz Pharmaceuticals; Juno Therapeutics; Neovii; Precision Biosciences; Rheos Medicines; Smart Immune; Takeda; Vor Biopharma
Expert Testimony - Pfizer
Travel, Accommodations, Expenses - Gilead Sciences
 
Shai Shimony
No Relationships to Disclose
 
Marlise Luskin
Consulting or Advisory Role - Jazz Pharmaceuticals; Kite, a Gilead company; Novartis; Pfizer
Research Funding - Abbvie (Inst); Novartis (Inst)
 
Jacqueline Garcia
Consulting or Advisory Role - Abbvie; Astellas Pharma; Genentech; MorphoSys; SERVIER
Research Funding - Abbvie (Inst); Genentech/Roche (Inst); Pfizer (Inst)
 
Evan Chen
Honoraria - Abbvie; Sermo
Consulting or Advisory Role - Guidepoint Global; Lumanity; Rigel
Research Funding - Abbvie
 
Eric Winer
Consulting or Advisory Role - Curis; Jazz Pharmaceuticals
 
Richard Stone
Honoraria - DAVA Pharmaceuticals; Medscape; Research to Practice
Consulting or Advisory Role - Abbvie; Amgen; Aptevo Therapeutics; AvenCell; BerGenBio; Bristol Myers Squibb; Celularity; CTI BioPharma Corp; Curis Oncology; Daiichi Sankyo Europe GmbH; ENSEM; Epizyme; GlaxoSmithKline; Glycomimetrics; Hermavant; Janssen; Jazz Pharmaceuticals; Kura Oncology; Lava Therapeutics; Ligand; Novartis; Redona Therapeutics; Rigel; Syndax; Syntrix Biosystems; Takeda
Research Funding - Abbvie/Genentech (Inst); Janssen Oncology (Inst); Novartis (Inst); Syndax (Inst)
 
Daniel DeAngelo
Consulting or Advisory Role - Amgen; Blueprint Medicines; Gilead Sciences; Incyte; Jazz Pharmaceuticals; Novartis; Pfizer; servier; takeda
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); glycomimetics (Inst); Novartis (Inst)
 
Najla Al Ali
No Relationships to Disclose
 
Corey Cutler
Stock and Other Ownership Interests - 2seventy bio; Actinium Pharmaceuticals; Alimera Sciences; Bluebird Bio; Northwest Biotherapeutics; Verastem
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Cimeio Therapeutics; CSL Behring; CTI BioPharma Corp; Deciphera; Incyte; InhibRx; Janssen; Jasper Therapeutics; Jazz Pharmaceuticals; Omeros; Oxford Immunotec; Rigel; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; CareDX; Cimeio Therapeutics; CTI BioPharma Corp; Editas Medicine; Equillium; Incyte; Jazz Pharmaceuticals; Mallinckrodt/Therakos; Sanofi
 
Rami Komrokji
Stock and Other Ownership Interests - Abbvie
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; DSI; Genentech; Geron; Janssen; Jazz Pharmaceuticals; Pharmaessentia; Rigel; Servio; SOBI; Sumitomo Pharma Oncology
Speakers' Bureau - Jazz Pharmaceuticals; Pharmaessentia; Rigel; SERVIER; SOBI
Research Funding - Bristol-Myers Squibb/Celgene (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Jazz Pharmaceuticals; Pharmaessentia
 
Maximilian Stahl
Consulting or Advisory Role - Boston Consulting Group; Clinical Care Options; Curis Oncology; GlaxoSmithKline; Haymarket; Kymera; Novartis; Sierra Oncology